IRMD · Insider Trading
iRadimed Corporation
Every open-market purchase and sale reported by IRMD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-25 | Joe E Kiani | Director | M | +698 | — |
| 2026-09-08 | Monty K Allen | Director | Sell | −1,419 | −$122.62K |
| 2026-06-23 | John Glenn | CFO | MIXED | +3,477 | −$213.81K |
| 2026-06-04 | Hilda Frederique Scharen-Guivel | Director | Sell | −3,000 | −$285.00K |
| 2026-06-02 | Roger E. Susi | CEO, President, Chairman | Sell | −2,500 | −$226.51K |
| 2026-05-28 | Roger E. Susi | CEO, President, Chairman | Sell | −7,500 | −$691.04K |
| 2026-05-20 | Roger E. Susi | CEO, President, Chairman | Sell | −7,500 | −$657.26K |
| 2026-05-13 | Roger E. Susi | CEO, President, Chairman | Sell | −7,500 | −$631.34K |
| 2026-05-06 | Roger E. Susi | CEO, President, Chairman | Sell | −7,500 | −$642.86K |
| 2026-04-22 | Roger E. Susi | CEO, President, Chairman | Sell | −7,500 | −$694.12K |
| 2026-04-15 | Roger E. Susi | CEO, President, Chairman | Sell | −7,500 | −$697.19K |
| 2026-04-07 | Roger E. Susi | CEO, President, Chairman | Sell | −7,500 | −$717.21K |
| 2026-04-01 | Roger E. Susi | CEO, President, Chairman | Sell | −7,500 | −$712.61K |
| 2026-03-25 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −7,500 | −$752.61K |
| 2026-03-18 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −7,500 | −$762.97K |
| 2026-03-10 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −7,500 | −$750.48K |
| 2026-03-09 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −7,500 | −$737.92K |
| 2026-03-05 | Jeff Chiprin | Chief Commercial Officer | A | +1,150 deriv. | — |
| 2026-03-05 | John Glenn | CHIEF FINANCIAL OFFICER | A | +8,907 deriv. | — |
| 2026-02-13 | Monty K Allen | Director | Sell | −1,000 | −$100.26K |
| 2026-01-27 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$503.26K |
| 2026-01-21 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$509.22K |
| 2026-01-13 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$487.23K |
| 2026-01-06 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$488.42K |
| 2025-12-30 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$488.32K |
| 2025-12-22 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$483.67K |
| 2025-12-17 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$483.73K |
| 2025-12-15 | Monty K Allen | Director | A | +1,026 deriv. | — |
| 2025-12-15 | James B Hawkins | Director | A | +1,026 deriv. | — |
| 2025-12-15 | Hilda Frederique Scharen-Guivel | Director | A | +1,026 deriv. | — |
| 2025-12-12 | Jeff Chiprin | Chief Commercial Officer | MIXED | +687 | −$30.09K |
| 2025-12-12 | James B Hawkins | Director | M | +905 | — |
| 2025-12-12 | Hilda Frederique Scharen-Guivel | Director | M | +905 | — |
| 2025-12-12 | Monty K Allen | Director | M | +905 | — |
| 2025-12-12 | John Glenn | CHIEF FINANCIAL OFFICER | MIXED | −13,902 | −$1.53M |
| 2025-12-10 | James B Hawkins | Director | Sell | −3,000 | −$289.84K |
| 2025-12-10 | John Glenn | CHIEF FINANCIAL OFFICER | MIXED | +19,862 | −$1.10M |
| 2025-12-09 | Monty K Allen | Director | M | +1,197 | — |
| 2025-12-09 | Hilda Frederique Scharen-Guivel | Director | M | +1,197 | — |
| 2025-12-09 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$477.16K |
| 2025-12-09 | James B Hawkins | Director | M | +1,197 | — |
| 2025-12-02 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$463.79K |
| 2025-11-24 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$451.81K |
| 2025-11-21 | James B Hawkins | Director | Sell | −3,000 | −$264.72K |
| 2025-11-19 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$427.96K |
| 2025-11-12 | John Glenn | CHIEF FINANCIAL OFFICER | Sell | −10,651 | −$900.16K |
| 2025-11-12 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$426.19K |
| 2025-11-04 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$413.22K |
| 2025-10-29 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$388.43K |
| 2025-10-22 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | −5,000 | −$374.08K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Roger E. Susi | CEO, President, Chairman | 2,162,500 | $183.01M |
| James B Hawkins | Director | 29,647 | $2.51M |
| Monty K Allen | Director | 19,986 | $1.69M |
| Anthony Vuoto | Director | 15,985 | $1.35M |
| John Glenn | CFO | 14,256 | $1.21M |
| Hilda Frederique Scharen-Guivel | Director | 5,598 | $473.76K |
| Joe E Kiani | Director | 698 | $59.07K |
| Jeff Chiprin | Chief Commercial Officer | 687 | $58.14K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the IRMD quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.